20943 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
Isolated nucleotide sequences encoding GDF traps
#602FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITION FOR THE TREATMENT OF DISEASE
#603HAIR GROWTH METHODS USING FGFR3 EXTRACELLULAR DOMAINS
#604Human Notch1 decoys
#605SUSTAINED DRUG DELIVERY SYSTEM
#606Cell secreted proteins for the treatment of myocardial infarction
#607Adeno-associated virus virions with variant capsid and methods of use thereof
#608Treatment of heart failure and related conditions
#609Nogo receptor antagonists and methods of increasing neurite outgrowth
#610Method of treatment of cancers characterized by ligand-dependent activating mutations in FGFR2 with FGFR1 ECD proteins
#611Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same
#612Compositions for regulating iron homeostasis and methods of using same
#613INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA
#614Compounds and methods of modulating angiogenesis
#615Use of transforming growth factor-beta neutralizing antibodies and fusion proteins thereof in treating pain
#616Implantable therapeutic device
#617Compositions and methods for preventing erythropoietin-associated hypertension
#618METHOD OF TREATING VISION DISORDERS
#619Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
#620Inhibition of AXL signaling in anti-metastatic therapy
#621Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma
#622METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS
#623Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
#624Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-FU) and irinotecan (FOLFIRI)
#625Immunotherapy against ErbB-3 receptor
#626Methods for treating nervous system injury and disease
#627Syringe
#628Pharmaceutical composition comprising CCN5 for reducing cardiac fibrosis in a subject in need thereof
#629Cartilage oligomeric matrix protein (COMP)—growth factor complexes and uses thereof
#630Use of a VEGF antagonist to treat angiogenic eye disorders
#631Variant activin receptor polypeptides and uses thereof
#632Somatostatin receptor-based cancer therapy
#633Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damage
#634Stable liquid VEGF antagonist formulations
#635EGFR-based peptides
#636Use of GDF traps to treat anemia
#637Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor
#638Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
#639Vaccine for the prevention of the recurrence HER2/neu expressing cancer
#640High affinity binding site of HGFR and methods for identification of antagonists thereof
#641Angiogenesis-inhibiting peptide and application thereof
#642Modulation of activity of neurotrophins
#643METHODS OF TREATING CANCER
#644METHODS OF TREATING LIVER CONDITIONS USING NOTCH2 ANTAGONISTS
#645ACTRIIB-FC polynucleotides, polypeptides, and compositions
#646Hair growth methods using FGFR3 extracellular domains
#647Therapeutic compositions for the treatment of dry eye disease
#648Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
#649VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#650Inhibition of AXL signaling in anti-metastatic therapy
#651Transforming growth factor-beta (TGF-beta) antagonists for use in treating pain
#652FGFR extracellular domain acidic region muteins
#653Activin-actriia antagonists and uses for treating multiple myeloma
#654Variant activin receptor polypeptides and uses thereof
#655METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF GENETIC AND RETINAL DISEASE
#656Broad spectrum ErbB ligand binding molecules and methods for preparing and using them
#657STIMULATORY AUTO-ANTIBODIES TO THE PDGF RECEPTOR AS PATHOLOGY MARKER AND THERAPEUTIC TARGET
#658Use of FGFR1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in FGFR2
#659VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS AND USES THEREOF
#660FGFR1 extracellular domain combination therapies for lung cancer
#661Methods for treating nervous system injury and disease
#662COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS
#663DRG11-responsive (dragon) polypeptides
#664DRG11-responsive (DRAGON) gene family
#665DRG11-responsive (DRAGON) gene family
#666Stable liquid VEGF antagonist formulations
#667Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
#668Adeno-associated virus virions with variant capsid and methods of use thereof
#669Methods for treating a disease caused by choroidal neovascularization
#670Methods for increasing adiponectin
#671Methods for increasing thermogenic adipocytes
#672VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE THREATMENT OF EARLY STAGE TUMORS
#673Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
#674Fibroblast growth factor receptor-derived peptides binding to NCAM
#675Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
#676Method of promoting bone growth by an anti-activin A antibody
#677High affinity binding site of HGFR and methods for identification of antagonists thereof
#678Method for treating cancer or cancer metastasis
#679Dimer VEGF antagonist formulations
#680METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES
#681Implantable therapeutic device
#682VEGF antagonist formulations for intravitreal administration
#683IMMUNOTHERAPEUTIC AGENT
#684Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
#685Modulation of activity of neurotrophins
#686Treatment of Central Nervous System Disorders
#687Peptide for the prophylactic or therapeutic treatment of skin tumors in initial stages
#688Compositions and Methods for Preventing Erythropoietin-Associated Hypertension
#689Method for promoting bone growth using activin-actriia antagonists
#690Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
#691Isolated GDF trap polypeptide
#692Compositions and methods for treatment of angiogenesis-associated ocular disorders
#693VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#694METHOD FOR TREATING CONGENITAL MYOPATHY
#695EXENDINS TO LOWER CHOLESTEROL AND TRIGLYCERIDES
#696VEGF antagonist formulations for intravitreal administration
#697INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA
#698ERBB3 BASED METHODS AND COMPOSITIONS FOR TREATING NEOPLASMS
#699Human Notch3 based fusion proteins as decoy inhibitors of Notch3 signaling
#700Activin-actriia antagonists for inhibiting germ cell maturation
#701MATERIALS AND METHODS FOR INHIBITING CANCER CELL INVASION
#702Therapeutic compositions for the treatment of dry eye disease
#703Modulation of the TrpV: Vps10p receptor system for the treatment of pain
#704Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
#705Methods and compositions for the treatment and diagnosis of systemic anthrax infection
#706mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION
#707PHARMACEUTICALS FOR INFLUENCING THE REACTION OF THE HUMAN IMMUNE SYSTEM
#708ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF
#709Combination Comprising Combretastatin and Anticancer Agents
#710VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE TREATMENT OF EARLY STAGE TUMORS
#711Uses of Cerberus and derivatives thereof
#712Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
#713Myostatin inhibitor enhancement of musculoskeletal repair
#714METHODS TO REGULATE GLUCOSE METABOLISM
#715Cell-mediated delivery and targeted erosion of noncovalently crosslinked hydrogels
#716VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#717METHODS FOR TREATMENT AND DIAGNOSIS OF PSYCHIATRIC DISORDERS
#718Methods for increasing thermogenic adipocytes
#719Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#720VEGF antagonist formulations
#721CTL inducer composition
#722Methods of screening for neoplastic disease states
#723Actriib-Fc polynucleotides, polypeptides, and compositions
#724Methods of inhibiting photoreceptor apoptosis
#725COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#726Modulation of activity of proneurotrophins
#727Vaccine for the prevention of breast cancer relapse
#728Methods for increasing adiponectin in a patient in need thereof
#729Muller Cell Specific Gene Therapy
#730Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
#731VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#732Oncolytic Adenoviruses and Uses Thereof
#733FGFR extracellular domain acidic region muteins
#734Lyophilized VEGF antagonist formulations for intravitreal administration
#735Method of increasing red blood cell levels or treating anemia in a patient
#736DRG11-Responsive (DRAGON) Gene Family
#737Methods for inhibiting angiogenesis
#738USE OF ONCOLYTIC VIRUSES AND ANTIANGIOGENIC AGENTS IN THE TREATMENT OF CANCER
#739Method of promoting bone growth by an anti-activin B antibody
#740USE OF SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME
#741High affinity binding site of HGFR and methods for identification of antagonists thereof
#742Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
#743METHOD FOR THE TREATMENT OF ANTHRAX TOXICITY
#744Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
#745Methods and compositions for treating inflammatory conditions
#746NOVEL METHOD OF MODULATING BONE-RELATED ACTIVITY
#747COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#748STIMULATORY AUTO-ANTIBODIES TO THE PDGF RECEPTORS AS PATHOLOGY MARKER AND THERAPEUTIC TARGET
#749Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
#750METHODS AND COMPOSITIONS FOR THE PREPARATION AND USE OF TOXIN CONJUGATES
#751Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
#752Soluble Endoglin Compounds for the Treatment and Prevention of Cancer
#753VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#754Activin-ActRIIa antagonists and uses for treating multiple myeloma
#755Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
#756Activin-ActRIIa antagonists and uses for promoting bone growth
#757Nogo receptor antagonists
#758Method for promoting bone growth using activin-ActRIIa antagonists
#759Uses of cerberus, coco and derivatives thereof
#760Activin-actriia antagonists and uses for treating or preventing breast cancer
#761Use of TGF-β antagonists to limit nephrotoxicity of immunosuppressive agents
#762Combination comprising combretastatin and anticancer agents
#763Vascular endothelial cell growth factor antagonists and uses thereof
#764Vascular endothelial cell growth factor antagonists and uses thereof
#765Therapeutic methods using Smads
#766Methods for treating nervous system injury and disease
#767Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
#768Soluble ErbB3 and treatment of cancer
#769Neuregulin-1 transgenic mouse and methods of use
#770VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
#771Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
#772Neuropilin/VEGF-C/VEGFR-3 Materials and Methods
#773Compositions and methods for cell dedifferentiation and tissue regeneration
#774Use of VEGF inhibitors for treatment of eye disorders
#775Compositions and Methods for Treating Disease
#776Combination Therapy with Angiogenesis Inhibitors
#777Methods For Suppressing Tumor Proliferation
#778Frizzled proteins and detection and treatment of cancer
#779Vascular Endothelial Cell Growth Factor Antagonists
#780DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS
#781Use of genetically-and epigenetically-altered protocadherins in methods of diagnosing, prognosing, and treating cancer
#782Human DRG11-responsive axonal guidance and outgrowth of neurite (dragon) proteins and variants thereof
#783ErbB-3 based methods and compositions for treating neoplasms
#784STEM CELL THERAPY FOR CARDIAC VALVULAR DYSFUNCTION
#785Anticancer Agent Containing Minus-Strand Rna Virus
#786Anticancer agent containing dendritic cell having RNA virus transferred thereinto
#787VEGF antagonist formulations suitable for intravitreal administration
#788Tie Receptor and Tie Ligand Materials and Methods for Modulating Female Fertility
#789Modulation of activity of neurotrophins
#790Human hemojuvelin (HJV) or dragon-like 1 (DL-1) polypeptides and variants and uses thereof
#791Vascular endothelial cell growth factor antagonists and uses thereof
#792Pharmaceutical removal of vascular extensions from a degenerating disc
#793VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#794Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
#795Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth
#796Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
#797GDF-9/BMP-15 modulators for the treatment of bone disorders
#798Hemojuvelin or dragon-like 2 (DL-2) polypeptides and variants and uses thereof
#799Energy assisted stem cell extract
#800Methods of reducing skin damage and edema
#801Use of VEGF antagonists for the treatment of malignant gliomas
#802Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions
#803Pharmaceutical composition comprising TrkAIg2 for use in the prevention and/or treatment of cancer
#804VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
#805Methods of treating diseases with a VEGF antagonist
#806Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor
#807Compositions and methods involving MDA-7 for the treatment of cancer
#808Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
#809Inhibition of HMGB1 release by fetuin
#810Ocular gene therapy
#811VEGF antagonist formulations
#812Formulations and methods for delivery of growth factor analogs
#813Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
#814Method and composition for regulating the activity of regulatory t cells
#815Inhibiting development of microvessels within coronary or peripheral vessel walls for restenosis/atherosclerosis prevention or therapy
#816ActRII receptor polypeptides, methods and compositions
#817DRG11-responsive (DRAGON) gene family
#818Combination therapy for diabetes, obesity and cardiovascular diseases using GDF-8 inhibitors
#819Use of VEGF inhibitors for treatment of eye disorders
#820Compositions and methods for treatment of lymphatic and venous vessel arterialization
#821Vascular endothelial growth factor 2
#822Methods of treating type I diabetes by blocking VEGF-mediated activity
#823Promoting angiogenesis with netrin1 polypeptides
#824Method for treating cancer and increasing hematocrit levels
#825Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
#826Compositions and methods for modulating signaling mediated by IGF-1 receptor and erbB receptors
#827Use of VEGF inhibitors for treatment of eye disorders
#828Compositions and methods for preventing erythropoietin-associated hypertension
#829Method and composition for regulating activity of regulatory T cells
#830Vascular endothelial cell growth factor antagonists and uses thereof
#831Use of a VEGF antagonist in combination with radiation therapy
#832Agent for inducing or inhibiting an angiogenesis
#833Novel method of modulating bone-related activity
#834Use of a VEGF antagonist in combination with radiation therapy
#835Methods and compositions for use in interventional pharmacogenomics
#836Spondyloarthropathies
#837Vascular endothelial cell growth factor antagonists and uses thereof
#838Method of treating cancer with a VEGF antagonist and an anti-proliferative agent
#839Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders
#840VEGFR fusion protein pharmaceutical composition
#841ACTRIIB ligand trap compositions and uses thereof